Pulmonary Diffusing Capacity
"Pulmonary Diffusing Capacity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The amount of a gas taken up, by the pulmonary capillary blood from the alveolar gas, per minute per unit of average pressure of the gradient of the gas across the BLOOD-AIR BARRIER.
Descriptor ID |
D011653
|
MeSH Number(s) |
E01.370.386.700.650.650 G09.772.600
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Pulmonary Diffusing Capacity".
Below are MeSH descriptors whose meaning is more specific than "Pulmonary Diffusing Capacity".
This graph shows the total number of publications written about "Pulmonary Diffusing Capacity" by people in this website by year, and whether "Pulmonary Diffusing Capacity" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
2005 | 1 | 0 | 1 |
2008 | 0 | 1 | 1 |
2012 | 0 | 1 | 1 |
2014 | 0 | 4 | 4 |
2015 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pulmonary Diffusing Capacity" by people in Profiles.
-
Cognitive function in idiopathic pulmonary fibrosis. Chron Respir Dis. 2015 Nov; 12(4):365-72.
-
Antinuclear antibody-negative systemic sclerosis. Semin Arthritis Rheum. 2015 Jun; 44(6):680-6.
-
Pulmonary hypertension and interstitial lung disease within PHAROS: impact of extent of fibrosis and pulmonary physiology on cardiac haemodynamic parameters. Clin Exp Rheumatol. 2014 Nov-Dec; 32(6 Suppl 86):S-109-14.
-
Pleural plaques and their effect on lung function in Libby vermiculite miners. Chest. 2014 Sep; 146(3):786-794.
-
Contribution of CT quantified emphysema, air trapping and airway wall thickness on pulmonary function in male smokers with and without COPD. COPD. 2014 Sep; 11(5):503-9.
-
Human immunodeficiency virus infection as a prognostic factor in surgical patients with non-small cell lung cancer. Ann Thorac Surg. 2012 Feb; 93(2):405-12.
-
Outcome measures in the lung. Rheumatology (Oxford). 2008 Oct; 47 Suppl 5:v48-50.
-
Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study. Arthritis Rheum. 2005 Feb; 52(2):592-600.
-
Steroid-responsive interstitial lung disease in patients receiving 2'-deoxy-5-fluorouridine-infusion chemotherapy. A report of three cases. Cancer. 1995 May 15; 75(10):2558-64.
-
Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease. J Rheumatol. 1993 May; 20(5):838-44.